Ep. 12 - Is Breast Implant Illness Real? New Study Reveals Shocking Biomarker Shift After Explant Surgery

What if science could validate what thousands of women have already reported? In this episode of The Scalpel’s Edge, Dr. Tim Sayed unpacks a newly published study in Nature Portfolio that may mark a turning point in how we understand breast implant illness (BII). The study reveals a statistically significant spike in FGF-19—a critical metabolic and healing biomarker—after explant surgery, reinforcing what many in the BII community have experienced firsthand.But is this just a side effect of surgery, or a deeper signal of systemic change? Dr. Sayed breaks down the science in digestible terms, exploring the implications for inflammation, gut health, cognitive clarity, and long-term wellness. Whether you're skeptical or seeking answers, this episode offers a data-backed lens into one of the most polarizing topics in modern plastic surgery.Contact Dr. Tim Sayed:Phone: (858) 247-2933Email: [email protected]: timsayedmd.comInstagram: @timsayedmdYouTube: @TimsayedmdFacebook: Tim Sayed MD